- Tytuł:
- Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom
- Autorzy:
- Źródło:
- PharmacoEconomics. 40(3):323-339
Czasopismo naukowe